Aaron YelowitzApplied economist · University of Kentucky
Search
Historical

ECO 725 · Fall 2012

Health Economics

Historical syllabus; policies and dates reflect this term.

Archived syllabus. Policies, dates, assignments, and readings reflect Fall 2012.

Course information

ECO 725-001: HEALTH ECONOMICS Syllabus and Reading List, Fall 2012 University of Kentucky TR, 9:30-10:45 pm, B&E 314

Aaron Yelowitz 335W Business and Economics Email: aaron@uky.edu

Fall 2012 Office Hours: Tues/Thurs, 3:15-4:15 pm (or by appt.)

Course Goals

This course examines the organization, financing, and management of the U.S. health care system and programs, and emphasizes contemporary health policy concerns. By the end of the semester, students should have the institutional knowledge and analytic tools needed to contribute to current public policy debates about health and medical care.

Specifically,

  • Be familiar with basic facts about the U.S. health care system
  • Be familiar with the major economic issues in health care policy Have experience using economic policy analysis to evaluate public policy issues in health care

In addition, one of the main goals that I have an instructor is to encourage students to explore dissertations that involve the health care system.

Grading

In order to encourage students to conduct original research in health economics and move along on their dissertations, the grading will consist of the following:

  1. In class presentation (10%) – The field of health economics is vast, and the goal of the presentation is to teach the entire class about an explored aspect of health economics. The presentations will be around 15 minutes each, and probably take the final two class sessions (Dec. 4 and Dec. 6, 2012). You must have the topic of your presentation approved by me.
  2. Literature write-up (15%) – The goal here is to critically review & reconcile several published/unpublished papers. This will be due around the middle of the semester.
  3. Data Exercise (50%) – Students were assigned a focused, health-related empirical exercise using HCUP. Restricted data-access, certification-code, and transfer instructions are omitted from this public archive.
  4. Final exam (25%) – This will be on Tuesday, December 11, 2012 at 8 am, and will last for 2 hours.

My philosophy with graduate teaching is that the main goal is to move you toward writing a dissertation.

Readings

Many of the articles come from the Handbook of Health Economics (HHE), as well as the AER, QJE, JPE, and J. Health Economics. The HHE is expensive to buy, and many of the chapters in the HHE are freely available on the internet as NBER working papers or on the author’s web sites, so we will primarily focus on the topics where these free papers exist.

A. Overview of Health Economics and Health Insurance

  • J. Gruber, Public Finance and Public Policy, “Health Insurance I: Health Economics and Private Health Insurance,” 2005, Chapter 15.

  • J. Gruber, Public Finance and Public Policy, “Health Insurance II: Medicare, Medicaid, and Health Care Reform,” 2005, Chapter 16.

Difference-in-differences handout

  • M. Bertrand, E. Duflo, and S. Mullainathan, “How Much Should We Trust Differences-in-Differences Estimates?” Quarterly Journal of Economics, February 2004.

  • A. Garber and J. Skinner, “Is American Health Care Uniquely Inefficient?” Journal of Economic Perspectives, Vol. 22, No. 4, Fall 2008, p. 27-50.

B. Health Status

  • C. Ruhm, “Are Recessions Good For Your Health?” Quarterly Journal of Economics, May 2000.

  • D. Miller, M. Page, A. Huff Stevens and M. Filipski, “Why Are Recessions Good for Your Health?” American Economic Review,Vol. 99, No. 2, May 2009,p. 122-27.

C. The Demand for Medical Care

  • M. Feldstein, “The Welfare Loss of Excess Health Insurance,” Journal of Political Economy, 81(2), Part 1, March-April 1973, 251-280.

  • M. Grossman, “The Human Capital Model,” in Handbook of Health Economics, Volume 1B, Amsterdam, North Holland: 2000, Chapter 7.

  • M. Grossman, “On the Concept of Health Capital and the Demand for Health,” Journal of Political Economy, 80(2), March-April 1972, 223-255.

  • W. Manning, et al., “Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment,” American Economic Review, 77(3), June 1987, 251-277.

  • J. Newhouse, “Medical Care Costs: How Much Welfare Loss?”, Journal of Economic Perspectives, 6(3), Summer 1992, 3-21.

  • M. McClellan, B. McNeil, and J. Newhouse, “Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality?” Journal of the American Medical Association, 272(11), Sep 21 1994, 859-866.

D. Malpractice Law

  • D. Kessler and M. McClellan, “Do Doctors Practice Defensive Medicine?, Quarterly Journal of Economics, May 1996.

  • J. Currie, W. B. MacLeod, “First Do No Harm? Tort Reform and Birth Outcomes”, Quarterly Journal of Economics May 2008, Vol. 123, No. 2: 795–830.

E. Market Innovation - Supply Side Policies

  • S. Glied, “Managed Care,” in Handbook of Health Economics, Volume 1A, Amsterdam, North Holland: 2000, Chapter 13.

E.1 Evidence on Supply-side Changes

  • L. Baker, “The Effect of HMOs on Fee-For-Service Health Care Expenditures – Evidence from Medicare” Journal of Health Economics, 16(4), Aug 1997.

  • D. Cutler, “The Incidence of Adverse Medical Outcomes Under Prospective Payment,” Econometrica, 63(1), January 1995, 29-50.

  • J. Marton, A. Yelowitz, and J. Talbert, “A Tale of Two Cities? The Heterogeneous Impact of Medicaid Managed Care,” Working paper, 2011.

E.2 Evidence on Market Changes

  • D. Kessler and M. McClellan, “Is Hospital Competition Socially Wasteful,” Quarterly Journal of Economics, 115(2), May 2000, 577-615.

  • V. Ho and B. Hamilton, “Hospital Mergers and Acquistions: Does Market Consolidation Harm Patients?” Journal of Health Economics, 19, 2000, 767-791.

  • A. Chandra and D. Staiger, “Productivity Spillovers in Health Care: Evidence from the Treatment of Heart Attacks”, Journal of Political Economy 2007 115:1, 103-140.

  • L. Dafny, “How Do Hospitals Respond to Price Changes?” American Economic Review,. 95(5), December 2005, p. 1525-1547.

  • L. Dafny, “Are Health Insurance Markets Competitive?” American Economic Review, September 2010, 1399-1431.

F. Organizational Form and Performance

  • M. Duggan, “Hospital Ownership and Public Medical Spending,” Quarterly Journal of Economics Nov 2000.

  • K. Baicker and D. Staiger, “Fiscal Shenanigans, Targeted Federal Health Care Funds, and Patient Mortality”, Quarterly Journal of Economics February 2005, Vol. 120, No. 1: 345– 386.

  • D. Dranove, D. Kessler, M. McClellan, and M. Satterthwaite, “Is More Information Better? The Effects of 'Report Cards' on Health Care Providers,” Journal of Political Economy, 2003, 111(3), 555-588.

G. Public Health Insurance and Expanding Coverage

G.1 Medicare and Private Medigap

  • A. Finkelstein, 2007. “The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare,” Quarterly Journal of Economics, 122(1), February, 1–37.

  • A. Finkelstein, 2004. “Minimum Standards, Insurance Regulation and Adverse Selection: Evidence from the Medigap Market,” Journal of Public Economics, 88(12), 2515-2547.

  • A. Finkelstein and R. McKnight, 2005. “What Did Medicare Do (And Was It Worth It)?” NBER Working Paper 11609.

  • D. Card, C. Dobkin and N. Maestas, “The Impact of Nearly Universal Insurance Coverage on Health Care Utilization: Evidence from Medicare”, American Economic Review,Vol. 98, No. 5, December 2008, p. 2242-58.

  • H. Fang, M. Keane, and D. Silverman, “Sources of Advantageous Selection: Evidence from the Medigap Insurance Market”, Journal of Political Economy 2008 116:2, 303-350.

G.2 Medicaid

  • J. Currie and J. Gruber, “Saving Babies: The Efficacy and Cost of Recent Expansions of Medicaid Eligibility for Pregnant Women,” Journal of Political Economy, December 1996, 1263-1296.

  • J. Currie and J. Gruber, “Health Insurance Eligibility, Utilization of Medical Care, and Child Health,” Quarterly Journal of Economics, 111(2), May 1996, 431-466.

  • D. Cutler and J. Gruber, “Does Public Insurance Crowd Out Private Insurance?”, Quarterly Journal of Economics, 111(2), May 1996, 391-430.

  • J. Gruber and A. Yelowitz, “Public Health Insurance and Private Savings,” Journal of Political Economy,107(6), Dec 1999, 1249-1274.

  • A. Yelowitz, “The Medicaid Notch, Labor Supply, and Welfare Participation: Evidence From Eligibility Expansions,” Quarterly Journal of Economics, 110(4), Nov 1995, 909-939.

  • A. Finkelstein, S. Taubman, B. Wright, M. Bernstein, J. Gruber, J. Newhouse, H. Allen, K. Baicker, and Oregon Health Study Group, “The Oregon Health Insurance Experiment: Evidence from the First Year,” Quarterly Journal of Economics, 127(3), Aug 2012, 1057-1106.

G.3 Expanding Coverage

  • J. Gruber, “Incremental Universalism for the United States: The States Move First?” Journal of Economic Perspectives, Vol. 22, No. 4, Fall 2008, p. 51-68.

  • A. Yelowitz and M. Cannon, “The Massachusetts Health Plan: Much Pain, Little Gain,” Cato Policy Analysis No. 657, January 20, 2010.

  • M. Hackmann, J. Kolstad and A. Kowalski, “Health Reform, Health Insurance and Selection: Estimating Selection into Health Insurance Using the Massachusetts Health Reform,” NBER Working Paper 17748.

  • J. Kolstad and A. Kowalski, “The Impact of Health Care Reform on Hospital and Preventive Care: Evidence from Massachusetts,” NBER Working Paper 16012.

  • C. Courtemanche and D. Zapata, “Does Universal Coverage Improve Health? The Massachusetts Experience,” NBER Working Paper 17893.

  • Y. Antwi, A. Moriya, and K. Simon, “Effects of Federal Policy to Insure Young Adults: Evidence from the 2010 Affordable Care Act Dependent Coverage Mandate,” NBER Working Paper 18200.

  • J. Cantor, A. Monheit, D.DeLia, and K. Lloyd, “The Role of Federal and State Dependent Coverage Eligibility Policies on the Health Insurance Status of Young Adults,” NBER Working Paper 18254.

H. Adverse Selection and Moral Hazard

  • D. Cutler and S. Reber, “Paying for Health Insurance: The Tradeoff Between Competition and Adverse Selection,” Quarterly Journal of Economics, May 1998, 433-466.

  • M. Rothschild and J. Stiglitz, “Equilibrium in Competitive Insurance Markets: An Essay on the Economics of Imperfect Information,” Quarterly Journal of Economics, 90(4), November 1976, 629-650.

  • T. Buchmueller and J. DiNardo, 2002. “Did Community Rating Induce an Adverse Selection Death Spiral? Evidence from New York, Pennsylvania, and Connecticut,” The American Economic Review, 92(1), 280-294.

I. Health Insurance and the Labor Market & Income

  • J. Currie and B. Madrian, “Health, Health Insurance and the Labor Market” in Handbook of Labor Economics, O. Ashenfelter and D. Card (eds.), Chapter 50.

  • J. Currie and A. Yelowitz, “Health Insurance and Less Skilled Workers,” in Finding Jobs: Work and Welfare Reform, David Card and Rebecca Blank (eds.), New York: Russell Sage, 2000.

  • J. Gruber, “Health Insurance and the Labor Market,” in Handbook of Health Economics, Volume 1A, Amsterdam, North Holland: 2000, Chapter 12.

  • B. Madrian, “Employment-Based Health Insurance and Job Mobility: Is There Evidence of Job-Lock?” Quarterly Journal of Economics, 109(1), Feb. 1994, 27-54.

  • J. Gruber and J. Poterba, “Tax Incentives and the Decision to Purchase Health Insurance: Evidence From the Self Employed,” Quarterly Journal of Economics, 109(3), Aug 1994, 701-733.

  • L. Summers, 1989. “Some Simple Economics of Mandated Benefits,” The American Economic Review, Papers and Proceedings of the Hundred and First Annual Meeting of the American Economic Association., 79(2), May, 177-183.

  • C. Colla, W. Dow and A. Dube, “How Do Employers React to a Pay-or-Play Mandate? Early Evidence from San Francisco,” NBER Working Paper 16179.

  • C. Colla, W. Dow and A. Dube, “The Labor Market Impact of Employer Health Benefit Mandates: Evidence from San Francisco’s Health Care Security Ordinance,” NBER Working Paper 17198.

  • J. Kolstad and A. Kowalski, “Mandate-Based Health Reform and the Labor Market: Evidence from the Massachusetts Reform,” NBER Working Paper 17933.

J. Vulnerable Populations

  • J. Bound, “The Health and Earnings of Rejected Disability Insurance Applicants,” American Economic Review, 79(3), Jun 1989, 482-503.

  • D. Parsons “The Health and Earnings of Rejected Disability Insurance Applicants: Comment” American Economic Review, 81(5), Dec 1991, 1419-1426.

  • J. Bound “The Health and Earnings of Rejected Disability Insurance Applicants: Reply” American Economic Review, 81(5), Dec 1991, 1427-1434.

  • J. Bound and T. Waidmann, “Disability, Transfers, Self-Reported Health, and the Labor Force Attachment of Older Men: Evidence from the Historical Record,” Quarterly Journal of Economics, 107(4), Nov. 1992, 1393-1419.

  • J. Gruber, “Disability Insurance Benefits and Labor Supply,” Journal of Political Economy, 2000, 108(6).

  • D. Acemoglu and J. Angrist, “Consequences of Employment Protection? The Case of the Americans with Disabilities Act,” Journal of Political Economy, 2001, 109(5).

  • R. Frank and T. McGuire, “Economics and Mental Health,” in Handbook of Health Economics, Volume 1B, Amsterdam, North Holland: 2000, Chapter 16.

  • E. Norton, “Long Term Care,” in Handbook of Health Economics, Volume 1B, Amsterdam, North Holland: 2000, Chapter 17.

  • D. Almond, K. Chay, D. Lee, “The Costs of Low Birth Weight”,Quarterly Journal of Economics August 2005, Vol. 120, No. 3: 1031–1083.

  • D. Almond, J. Doyle, A. Kowalski and H. Williams, “Estimating Marginal Returns to Medical Care: Evidence from At-Risk Newborns,” Quarterly Journal of Economics, May 2010, 591-634.

  • A. Barreca, M. Guldi, J. Lindo and G. Waddell, “Saving Babies? Revisiting the Effect of Very Low Birth Weight Classification,” Quarterly Journal of Economics, 2011, 2117-2123.

  • D. Almond, J. Doyle, A. Kowalski and H. Williams, “The Role of Hospital Heterogeneity in Measuring Marginal Returns to Medical Care: A Reply to Barreca, Guldi, Lindo, and Waddell,” Quarterly Journal of Economics, 2011, 2125-2131.

  • S. Black, P. Devereux, and K. Salvanes, “From the Cradle to the Labor Market? The Effect of Birth Weight on Adult Outcomes”, Quarterly Journal of Economics February 2007, Vol. 122, No. 1: 409–439.

  • D. Almond, “Is the 1918 Influenza Pandemic Over? Long-Term Effects of In Utero Influenza Exposure in the Post-1940 U.S. Population,” Journal of Political Economy 2006 114:4, 672-712.

  • D. Almond and B. Mazumder, “The 1918 Influenza Pandemic and Subsequent Health Outcomes: An Analysis of SIPP Data”, American Economic Review, Vol. 95, No. 2, May 2005, p. 258-262.

K. Health Habits

  • F. Chaloupka and K. Warner, “The Economics of Smoking,” in Handbook of Health Economics, Volume 1B, Amsterdam, North Holland: 2000, Chapter 29.

  • F. Chaloupka, “Rational Addictive Behavior and Cigarette Smoking,” Journal of Political Economy, 99(4), Aug. 1991, 722-742.

  • J. Gruber and B. Kosegi, “Is Addition ‘Rational’? Theory and Evidence,” Quarterly Journal of Economics, November 2001.

  • P. Cook and M. Moore, “Alcohol,” in Handbook of Health Economics, Volume 1B,

Amsterdam, North Holland: 2000, Chapter 30.

  • D. Kenkel, “Health Behavior, Health Knowledge, and Schooling,” Journal of Political Economy, 99(2), Apr. 1991, 287-305.

  • R. Avery, D. Kenkel, D. Lillard, and A. Mathios, “Private Profits and Public Health: Does Advertising of Smoking Cessation Products Encourage Smokers to Quit?” Journal of Political Economy 2007 115:3, 447-481.

  • S. Levitt and J. Porter, “How Dangerous are Drinking Drivers?” Journal of Political Economy, 2001, 109(6).

L. The Environment and Health

  • K. Chay and M. Greenstone, “Air Quality, Infant Mortality, and the Clean Air Act of 1970,” August 2001, Mimeo, Berkeley.

  • K. Chay and M. Greenstone, “The Impact of Air Pollution on Infant Mortality: Evidence from Geographic Variation in Pollution Shocks Induced by a Recession”, Quarterly Journal of Economics August 2003, Vol. 118, No. 3: 1121–1167.

  • W. Troesken, “Lead Water Pipes and Infant Mortality in Turn-of-the-Century Massachusetts,” NBER Working Paper 9549, March 2003.

  • M. Greenstone, “The Impacts of Environmental Regulations on Industrial Activity: Evidence from the 1970 and 1977 Clean Air Act Amendments and the Census of Manufactures,” NBER Working Paper 8484, September 2001.

  • M. Neidell, “Air Pollution, Health, and Socio-Economic Status: The Effect of Outdoor Air Quality on Childhood Asthma,” Mimeo, UCLA, December 2001.

  • K. Chay and M. Greenstone, “Does Air Quality Matter? Evidence from the Housing Market”, Journal of Political Economy 2005 113:2, 376-424.

  • J. Currie and M. Neidell, “Air Pollution and Infant Health: What Can We Learn From California's Recent Experience?” Quarterly Journal of Economics August 2005, Vol. 120, No. 3: 1003–1030.

  • J. Currie and J. Schmieder, “Fetal Exposures to Toxic Releases and Infant Health”, American Economic Review, Vol. 99, No. 2, May 2009, p. 177-83.

M. Pharmaceutical Industry and Prescription Drug Abuse

F.M. Scherer, “The Pharmaceutical Industry,” in Handbook of Health Economics, Volume 1B, Amsterdam, North Holland: 2000, Chapter 25.

  • F. Lichtenberg, and T. Philipson, “The Dual Effects of Intellectual Property Regulations: Withinand Between- Patent Competition in the US Pharmaceuticals Industry,” NBER Working Paper 9303, October 2002.

  • F. Lichtenberg, and S. Virabhak, “Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as ‘equipment for your health’,” NBER Working Paper 9351, November 2002.

  • F. Lichtenberg, “The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001,” NBER Working Paper 9754, June 2003.

  • P. Danzon, Y. Wang, and L. Wang, “The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s,” NBER Working Paper 9874, July 2003.

  • A. Lleras-Muney and F. Lichtenberg, “The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs,” NBER Working Paper 9185

  • F. Lichtenberg, “The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output,” NBER Working Paper 9139

  • A. Finkelstein, 2004. “Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry,” Quarterly Journal of Economics, 119(2), 527–564, May.

  • M. Duggan and F. Scott Morton, 2006. “The Distortionary Effects of Government Procurement: Evidence From Medicaid Prescription Drug Purchasing,” Quarterly Journal of Economics, 121(1), 1-30, February.

  • M. Duggan and F. Scott Morton, 2010, “The Effect of Medicare Part D on Pharmaceutical Prices and Utilization,” 100(1), 590-607.

  • R. McKetin, et al, “A Systematic Review of Methamphetamine Precursor Regulations,” Addiction, 106, 111-1924.

  • J. Nonnemaker,M. Engelen, and D. Shive,”Are Methamphetamine Precursor Control Laws Effective Tools to Fight the Methampetamine Epidemic?” Health Economics, 2011, 519-531.

  • R. Simeone and L. Holland, “An Evaluation of Prescription Drug Monitoring Programs,” Working Paper, 2006.

  • S. Cunningham and K. Finlay, “Parental Substance Abuse and Foster Care: Evidence from Two Methamphetamine Supply Shocks,” Working Paper 1003, Tulane University, 2010.

  • J. Cunningham, et al., “Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: Impact on methamphetamine clandestine laboratory seizures,” Drug and Alcohol Dependence, forthcoming.

  • P. Freeman and J. Talbert, “Impact of State Laws Regulating Psuedoephedrine on Methamphetamine Trafficking and Abuse”, April 2012.

  • H. Mialon, E. Nesson and M. Samuel, “Crystal Clear? The Relationship Between Methamphetamine Use and Risky Sexual Behavior,” Working Paper, Emory University.